Loading…
Loading…
EQUITY / NASDAQ · XNCM
Charming Medical Limited
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2025 – 03/31/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗29.355 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 29.355 USD · Volume 0
20 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
4 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2025 – 03/31/2026 · Units
| Metric | 2026 / Year end | 2025 / Year end | Change |
|---|---|---|---|
| Revenue | 4,807,713 USD | 6,221,751 USD | -22.73% |
| Operating profit | -29,237 USD | 1,388,938 USD | -102.10% |
| Net income | -22,648 USD | 1,199,085 USD | -101.89% |
| Operating cash flow | -1,215,931 USD | 425,888 USD | -385.50% |
| Cash and cash equivalents | 4,699,273 USD | 816,771 USD | +475.35% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Year end04/01/2025 – 03/31/2026ConsolidatedUnits · USD | 2025 / Year end04/01/2024 – 03/31/2025ConsolidatedUnits · USD | 2024 / Year end04/01/2023 – 03/31/2024ConsolidatedUnits · USD | 2023 / Year end03/31/2023 – 03/31/2023ConsolidatedUnits · USD |
|---|---|---|---|---|
| Capital expendituresCash flow statement | 339,560 USD | 287,527 USD | 210,598 USD | — |
| Cash and cash equivalentsBalance sheet | 4,699,273 USD | 816,771 USD | — | — |
| Financing cash flowCash flow statement | 5,292,156 USD | 521,303 USD | 100,145 USD | — |
| Investing cash flowCash flow statement | -179,015 USD | -2,229,458 USD | -210,598 USD | — |
| Net incomeIncome statement | -22,648 USD | 1,199,085 USD | 777,811 USD | — |
| Operating cash flowCash flow statement | -1,215,931 USD | 425,888 USD | 295,429 USD | — |
| Operating profitIncome statement | -29,237 USD | 1,388,938 USD | 1,008,848 USD | — |
| RevenueIncome statement | 4,807,713 USD | 6,221,751 USD | 6,015,375 USD | — |
| Total assetsBalance sheet | 9,868,667 USD | 5,355,741 USD | — | — |
| Total equityBalance sheet | 5,180,962 USD | 49,243 USD | -1,146,068 USD | -1,268,823 USD |
| Total liabilitiesBalance sheet | 4,687,705 USD | 5,306,498 USD | — | — |
| Report source | Open report ↗ Published: 07/30/2026 | Open report ↗ Published: 07/30/2026 | Open report ↗ Published: 07/30/2026 | Open report ↗ Published: 07/30/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.